secwatch.observer — SEC 8-K summary
======================================

Issuer:     Centessa Pharmaceuticals plc (CNTA)
CIK:        0001847903
Form:       8-K
Filed at:   2026-05-22T20:15:48+00:00
Accession:  0001193125-26-236933
Event type: m_and_a
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

HSR waiting period expires for Lilly's acquisition of Centessa; condition satisfied
--------------------------------------------------------------------------------

- Hart-Scott-Rodino waiting period expired at 11:59 p.m. on May 21, 2026, clearing antitrust review.
- Acquisition of Centessa by Eli Lilly announced March 31, 2026; remains subject to shareholder vote and court sanction.
- Proxy statement filed May 7, 2026; shareholders urged to vote on the scheme of arrangement.
- Closing requires approval by Centessa shareholders and sanction by High Court of Justice of England and Wales.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847903/000119312526236933/0001193125-26-236933-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847903/000119312526236933/d156443d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-236933

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer